Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Indian J Nephrol ; 28(3): 232-235, 2018.
Article in English | MEDLINE | ID: mdl-29962676

ABSTRACT

Invasive fungal infection is a complication seen in immunocompromised patients. A disseminated fungal infection has a high rate of mortality. Although disseminated infection is known to be seen in most organs, thyroid involvement is rarely reported. Hence, we report a fatal case of thyroid mucormycosis which resulted into laryngeal nerve paralysis and death of a renal allograft recipient.

2.
Indian J Med Microbiol ; 30(3): 367-70, 2012.
Article in English | MEDLINE | ID: mdl-22885213

ABSTRACT

Idiopathic CD4 lymphocytopenia (ICL) is a rare disorder which is often diagnosed as HIV-negative AIDS in the light of poor immunity and AIDS-defining illnesses. We present a case of a 50-year-old male who presented with a midline posterior fossa tumour with ICL diagnosed as cerebellar cryptococcoma.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Central Nervous System Fungal Infections/diagnosis , Central Nervous System Fungal Infections/pathology , Cryptococcosis/diagnosis , Cryptococcosis/pathology , Lymphopenia/complications , Lymphopenia/diagnosis , Central Nervous System Fungal Infections/microbiology , Cerebellum/diagnostic imaging , Cerebellum/pathology , Cryptococcosis/microbiology , Cryptococcus neoformans/isolation & purification , Humans , Male , Middle Aged , Tomography, X-Ray Computed
3.
Med Mycol ; 45(5): 457-61, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17654273

ABSTRACT

Zygomycosis is an invasive, life threatening fungal infection that usually affects immunocompromised hosts. In the head and neck region, rhino-orbito-cerebral zygomycosis is more common than the cervicofacial variety. We report the first case of otogenic cervicofacial zygomycosis caused by Apophysomyces elegans involving the salivary glands, an uncommon site of infection. The case began after a trivial trauma in a diabetic patient and despite surgical debridement and liposomal amphotericin B therapy, the patient died due to extensive involvement and metabolic/hemodynamic complications.


Subject(s)
Facial Paralysis/microbiology , Mucorales/isolation & purification , Mucormycosis/microbiology , Otitis/microbiology , Sialadenitis/microbiology , Acute Disease , Adult , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Diabetes Complications , Facial Paralysis/drug therapy , Facial Paralysis/pathology , Fatal Outcome , Humans , Male , Mucorales/classification , Mucormycosis/drug therapy , Mucormycosis/pathology , Otitis/drug therapy , Otitis/pathology , Parotid Gland/microbiology , Parotid Gland/pathology , Parotitis/drug therapy , Parotitis/microbiology , Parotitis/pathology , Salivary Glands/microbiology , Salivary Glands/pathology , Sialadenitis/drug therapy , Sialadenitis/pathology
4.
Indian J Med Res ; 116: 5-12, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12514972

ABSTRACT

BACKGROUND & OBJECTIVES: As a marked increase in the number of patients with candidaemia was reported in the first half (1991-1995) of the last decade at the Postgraduate Institute of Medical Education & Research, Chandigarh, India, the present study was aimed at determining further change if any, in the incidence and distribution of Candida species and their antifungal resistance pattern during the second half (1996-2000) of the same decade. METHODS: The patients with candidaemia were studied to determine the frequency of candidaemia and Candida species isolated during 1996-2000. One hundred Candida strains other than Pichia anomala (C. pelliculosa) were randomly selected from those isolates to evaluate antifungal susceptibility pattern against amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. The results were compared with our previous study. RESULTS: An increase in the number of patients with candidaemia was observed during 1996 (538) and 1997 (421) compared to 1998-2000 due to P. anomala outbreak. With the control of the outbreak, a substantial decrease in the incidence of candidaemia was observed from 1998 (251 in 1998, 122 in 1999 and 165 in 2000). A higher isolation of non-C. albicans Candida species (89.8%) was observed, with C. tropicalis being the most common (541, 36.1%) agent. No major change in the isolation rate of other non-C. albicans Candida species (C. guilliermondii, C. krusei, C. glabrata and C. parapsilosis) was observed. An emergence of resistance to amphotericin B in 15.4 per cent C. albicans, 8.1 per cent C. tropicalis and 33.3 per cent C. krusei strains was observed. An increase in resistance to ketoconazole (from 0% to 13%) and 5-fluorocytosine (from 1% to 8%) and a decrease to fluconazole (from 13% to 6%) were observed. Resistance to itraconazole was observed in 17 per cent of Candida strains by broth macro-dilution method. INTERPRETATION & CONCLUSION: A change in the isolation of Candida species was observed i.e. in the incidence and isolation of non-C. albicans Candida species. Emergence of resistance to amphotericin B and increase of resistance to most other antifungals are cause for concern.


Subject(s)
Antifungal Agents/therapeutic use , Candida/drug effects , Candida/genetics , Candidiasis/blood , Candidiasis/microbiology , Candidiasis/drug therapy , Humans , Microbial Sensitivity Tests , Random Allocation , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...